A cross of mice that are heterozygous for each of three unlinked genes must produce 146 offspring for a 90% probability that one will be triple homozygous mutant. The likelihood decreases further if any of the three mutations are genetically linked but on opposite homologous chromosomes, since recombination events that combine alleles onto the same chromosome would be very infrequent. The cost, time, and requirement for a large number of mice to obtain a few individuals of the desired genotype are therefore prohibitive for certain complex models of multigenic evolutionary traits or human diseases, like arthritis and cancer.

Recently, CRISPR/Cas9-mediated gene drive systems were developed in *Drosophila* and Anopheline mosquitoes that increase the frequency of inheritance of desired alleles^[@R1]--[@R4]^. These utilized genetic elements, which we refer to broadly as "active genetic elements", that can carry transgenes or orthologous sequences from other species^[@R5]^. Critically, an active genetic element includes a guide RNA (gRNA) and is inserted into the genome at the precise location that is targeted for cleavage by the encoded gRNA. In a heterozygous animal that also expresses the Cas9 nuclease, the gRNA targets cleavage of the wild type homologous chromosome. Genomic sequences that flank the active genetic element then resolve the double strand break (DSB) by homology directed repair (HDR), which copies the active genetic element from donor to receiver chromosome and converts the heterozygous genotype to homozygosity. The frequency of transmitting the active genetic element to the next generation is therefore greater than expected by random segregation of heterozygous alleles and is referred to as "super-Mendelian". In addition to the potential to surmount the obstacles of assembling complex genotypes in laboratory rodents, variations of a CRISPR/Cas9-mediated system have been proposed that might suppress invasive rodent populations and/or reduce the impacts of rodent-borne disease^[@R6],[@R7]^.

Despite the high efficiency observed in insects, divergence over 790 million years since their last common ancestor with mammals presents two potential obstacles to implementation of active genetics in mice; the frequency of DSB formation using genetically encoded Cas9 and gRNA and/or of HDR may preclude efficient gene conversion. The alternative DSB repair pathway, non-homologous end joining (NHEJ), frequently generates small insertions or deletions, known as "indels", that make CRISPR/Cas9 an effective means of mutating specific sites in the genome. Although HDR of CRISPR/Cas9 induced DSBs does occur *in vitro* and *in vivo* in mammalian cells and embryos, usually from a plasmid or single stranded DNA template, NHEJ is the predominant mechanism of DSB repair in somatic cells^[@R8],[@R9]^.

To assess the feasibility of active genetic systems in mice, we designed a "CopyCat" element^[@R10]^ that differs from the genetic element used initially in insects in that it cannot self-propagate because it encodes a gRNA but not the Cas9 protein ([Fig. 1a](#F1){ref-type="fig"}). We designed our strategy to disrupt the *Tyrosinase* gene (*Tyr*), because of the obvious albino phenotype of homozygous loss-of-function animals^[@R11]^ and to make use of a previously characterized *Tyr* gRNA with high activity^[@R12]^. [Extended Data Fig. 1](#F4){ref-type="fig"} illustrates the insertion of this element precisely into the gRNA cut site in exon 4 of *Tyr* to obtain the *Tyr^CopyCat^* knock-in allele ([Supplementary Methods](#SD2){ref-type="supplementary-material"} and [Supplementary Fig. 1, 2](#SD2){ref-type="supplementary-material"}). Briefly, the *Tyr* gRNA is transcribed from a constitutive human RNA polymerase III U6 promoter^[@R13]^. On the reverse strand of DNA, to minimize possible transcriptional conflict, mCherry is ubiquitously expressed from the human cytomegalovirus (CMV) immediate-early promoter and enhancer^[@R14]^. Since the 2.8 kb insert disrupts the *Tyr* open reading frame, *Tyr^CopyCat^* is a functionally null (albino) allele that is propagated by Mendelian inheritance in absence of Cas9. Crossing mice that carry the *Tyr^CopyCat^* element to transgenic mice that express Cas9 allows us to test whether it is possible to observe super-Mendelian inheritance of the *Tyr^CopyCat^* allele. For this analysis, we assessed eight different genetic strategies using existing tools that provide spatial and temporal control of Cas9 expression in the early embryo and in the male and female germlines.

We employed two "constitutive" *Cas9* transgenic lines, *Rosa26-Cas9*^[@R15]^ and *H11-Cas9*^[@R16]^, that reportedly express Cas9 in all tissues that have been assessed. Each is driven by a ubiquitous promoter and is placed in the respective *Rosa26* or *H11* "safe harbor" locus. In order to track inheritance of the chromosome that is targeted for gene conversion, we bred the *chinchilla* allele of *Tyrosinase* (*Tyr^c-ch^*, here simplified to *Tyr^ch^*) into each *Cas9* transgenic line. *Tyr^ch^* encodes a hypomorphic point mutation in exon 5 that is tightly linked to the gRNA target site in exon 4. *Tyr^ch^* homozygotes or heterozygotes complementing a null allele have a grey coat color, and the G to A single nucleotide polymorphism can be scored with certainty by PCR followed by DNA sequencing^[@R17]^ ([Supplementary Fig. 4](#SD2){ref-type="supplementary-material"}).

Female *Rosa26-Cas9*; *Tyr^ch/ch^* and *H11-Cas9*; *Tyr^ch/ch^* mice were each crossed to *Tyr^CopyCat/+^* males to unite the gRNA and Cas9 protein in the early embryo ([Fig. 1b](#F1){ref-type="fig"}). In absence of a loss-of-function mutation in exon 4 of the receiver chromosome, *Tyr^CopyCat/ch^* mice should appear grey (see *Cas9-*; *Tyr^CopyCat/ch^* mice in [Fig. 1d](#F1){ref-type="fig"}). However, we did not observe any grey *Cas9+*; *Tyr^CopyCat/ch^* mice in the F2 offspring of either cross. Instead, all 17 of the *Rosa26-Cas9*; *Tyr^CopyCat/ch^* mice were entirely white. Among *H11-Cas9*; *Tyr^CopyCat/ch^* mice, 21 of the F2 progeny (87.5%) were a mosaic mixture of grey and white fur, and three mice (12.5%) were entirely white ([Fig. 1d, e](#F1){ref-type="fig"} and [Extended Data Table 1](#T2){ref-type="table"}). The prevalence of mosaicism in the *H11-Cas9* strategy, compared to the all-white mice produced by *Rosa26-Cas9*, suggests that there may be a difference in the level and/or timing of Cas9 expression driven by these two transgenes.

Our next goal was to determine what type of repair events (NHEJ mutations or gene conversions by HDR) were transmitted to the next generation. In order to assess inheritance in many offspring, we crossed each F2 male *Rosa26-Cas9*; *Tyr^CopyCat/ch^* and *H11-Cas9*; *Tyr^CopyCat/ch^* mouse to multiple albino CD-1 females ([Fig. 1c](#F1){ref-type="fig"}), which carry a loss-of-function point mutation in *Tyr* exon 1 (*Tyr^c^*, here designated as *Tyr^null^*)^[@R11],[@R17]^. We then genotyped F3 offspring of this test cross by PCR and DNA sequencing exon 5 to identify those that inherited the *Tyr^ch^*-marked receiver chromosome ([Supplementary Fig. 4](#SD2){ref-type="supplementary-material"}). In the absence of gene conversion, effectively none of these chromosomes would be predicted to also carry the *Tyr^CopyCat^* allele due to separation of *Tyr* exons 4 and 5 by only \~9.1 kb.

*Tyr^ch/null^* animals should appear grey due to partial activity of the hypomorphic *Tyr^ch^* allele. However, among F3 offspring with this genotype, 100% in the *Rosa26-Cas9* lineage and 90.4% in the *H11-Cas9* lineage were completely white, indicating frequent transmission of a CRISPR/Cas9 induced loss-of-function mutation on the receiver chromosome and consistent with the primarily albino coat color of the F2 parents ([Fig. 1c](#F1){ref-type="fig"} and [Extended Data Table 1](#T2){ref-type="table"}, [2](#T3){ref-type="table"}). If the induced null alleles resulted from inter-homologue HDR to copy the *Tyr^CopyCat^* allele from the donor to the *Tyr^ch^*-marked receiver chromosome, these white animals should also express the fluorescent mCherry marker. In these experiments, however, none of the F3 offspring that inherited the receiver chromosome in either the *Rosa26-Cas9* or *H11-Cas9* lineages expressed mCherry. PCR amplification of *Tyr* exon 4 confirmed that the *Tyr^CopyCat^* element was not present in white *Tyr^ch/null^* F3 progeny ([Extended Data Table 2](#T3){ref-type="table"}).

The different propensities to yield full albino versus mosaic coat color patterns in the *Rosa26-Cas9* and *H11-Cas9* lineages were paralleled by differences in the number of unique NHEJ mutations that we identified on receiver chromosomes in individuals of each genotype. Sequenced PCR products from *Rosa26-Cas9*; *Tyr^CopyCat^* F2 tails (somatic tissues comprised of both ectodermal and mesodermal derivatives) and from individual F3 outcross offspring (representing the germline) typically exhibited only two unique NHEJ mutations suggesting that many of these Cas9 induced mutations may have been generated in 2--4 cell stage embryos (average 2.4 alleles among offspring of five families; [Extended Data Fig. 2](#F5){ref-type="fig"} and [Extended Data Table 3](#T4){ref-type="table"}). In contrast, *H11-Cas9*; *Tyr^CopyCat^* F2 tails and F3 offspring harbored significantly more unique NHEJ mutations (average 4.6 alleles in five families; two-tailed Student's t-test, p=0.041), consistent with the hypothesis that Cas9 is expressed at a later embryonic stage and/or at lower levels in this lineage.

We considered two explanations for the observation that *Tyr^CopyCat^* was not copied to the receiver chromosome in the early embryo. The first possibility is that homologous chromosomes are not aligned for inter-homologue HDR to repair DSBs. Second, the DNA repair machinery in somatic cells typically favors NHEJ over HDR^[@R8],[@R9]^. A possible solution to overcome both potential obstacles is to restrict CRISPR/Cas9 activity to coincide with meiosis in the developing germline. During meiosis, recombination of the maternal and paternal genomes is initiated by the formation of DSBs that are repaired by exchanging regions of homologous chromosomes that are physically paired during Meiosis I^[@R18]^. Indeed, the molecular mechanisms of NHEJ are actively repressed to favor HDR during meiosis in many species, including mice^[@R19]^.

In order to test the hypothesis that CRISPR/Cas9 activity will convert a heterozygous active genetic element to homozygosity during meiosis, we designed a crossing scheme to initiate Cas9 expression during germline development in *Tyr^CopyCat/ch^* mice. Since no currently available transgenic mice express Cas9 under direct control of a germline-specific promoter, we combined conditional *Rosa26-* or *H11-LSL-Cas9* transgenes, each with a Lox-Stop-Lox preceding the Cas9 translation start site^[@R15],[@R16]^, with available *Vasa-Cre* or *Stra8-Cre* germline transgenic mice. *Vasa-Cre* is expressed later than the endogenous *Vasa* transcript in both male and female germ cells^[@R20]^ while *Stra8-Cre* is limited to the male germline and is initiated in early stage spermatogonia^[@R21]^. Although oogonia and spermatogonia are pre-meiotic, and spermatogonia are in fact mitotic, we reasoned that Cre protein must first accumulate before *Cas9* can be expressed from the *LSL-Cas9* conditional allele. The possible time delay may require initiation of *Cre* expression before the onset of meiosis so that Cas9-induced DSBs can be resolved by inter-homologue HDR prior to segregation of homologous chromosomes at the end of Meiosis I. We generated each combination of these *Cre* and conditional *Cas9* lines in case the timing or levels of Cas9 expression are critical variables in these crosses. We also assessed males and females of the *Vasa* strategies in case there are sex-dependent differences in animals that inherit the same genotype.

Males heterozygous for *Tyr^CopyCat^* and the *Vasa-Cre* transgene were crossed to females homozygous for both the *Tyr^ch^* allele and one of the two conditional *Cas9* transgenes ([Fig. 2](#F2){ref-type="fig"}). We avoided the reverse cross using female *Vasa-Cre* mice, since Cre protein maternally deposited in the egg^[@R20]^ might induce recombination of the conditional *Cas9* allele and induce mutations in the early embryo similar to what we observed in the experiments using constitutive *Cas9* transgenes. Introducing the *Vasa-Cre* transgene by inheritance from the male instead resulted in most offspring that were entirely grey, due to the *Tyr^CopyCat/ch^* genotype, and a few mosaic animals ([Supplementary Table 4](#SD2){ref-type="supplementary-material"}). The presence of any mosaicism suggests that this conditional approach to restrict *Cas9* expression to the germline resulted in some spurious cleavage of the *Tyr* locus in somatic tissues.

We first tested whether Cas9 in the female germline could promote copying of the *Tyr^CopyCat^* element onto the receiver chromosome by crossing F3 female mice of each *Vasa-Cre* lineage to CD-1 (*Tyr^null^*) males. In each cross, we identified F4 offspring that inherited the *Tyr^ch^*-marked chromosome ([Fig. 2](#F2){ref-type="fig"}). As in the crosses to assess the effects of embryonic *Cas9* expression, we expected *Tyr^ch/null^* mice without a loss-of-function mutation in exon 4 of the receiver chromosome would be grey. Mice with a CRISPR/Cas9 induced NHEJ mutation in exon 4 should be white. Similarly, mice carrying a CRISPR/Cas9 induced mutation that was repaired by inter-homologue HDR should also be white, but should additionally fluoresce red due to transmission of the *mCherry*-marked *Tyr^CopyCat^* active genetic element.

[Table 1](#T1){ref-type="table"} summarizes the results of these crosses that demonstrate gene conversion upon Cas9 expression in the female germline. In contrast with early embryonic expression of *Cas9*, we observed that the *Tyr^CopyCat^* transgene was copied to the *Tyr^ch^*-marked receiver chromosome in both *Vasa-Cre*; *Rosa26-LSL-Cas9* and *Vasa-Cre*; *H11-LSL-Cas9* lineages. However, the observed efficiency differed between genotypes; three out of five females of the *Vasa-Cre*; *Rosa26-LSL-Cas9* lineage and all five of five females of the *Vasa-Cre*; *H11-LSL-Cas9* lineage transmitted a *Tyr^ch^*-marked chromosome containing a *Tyr^CopyCat^* insertion to at least one offspring. Although there was considerable variation among females with the same genotype, the highest observed frequency of gene conversion (72.2%) within a germline produced 13 out of 18 *Tyr^ch^* offspring with a *Tyr^CopyCat^* insertion in the *Vasa-Cre*; *H11-LSL-Cas9* lineage ([Table 1](#T1){ref-type="table"} and [Extended Data Table 4](#T5){ref-type="table"}). The probability of obtaining an animal with this genotype by natural meiotic recombination mechanisms is very low (4.7×10^−5^) due to ultra-tight linkage between the *Tyr^CopyCat^* and *Tyr^ch^* alleles. Although it seems likely that inter-homologue HDR of Cas9-induced DSBs utilizes the same DNA repair machinery that is active during meiotic recombination, these copying events cannot be explained by an increased incidence of chromosomal crossover, since all animals that inherited the donor chromosome lacking the *Tyr^ch^* marker expressed mCherry ([Extended Data Table 4](#T5){ref-type="table"}).

In contrast to the 41 copying events we observed out of 132 total *Tyr^ch/null^* offspring of female mice, we observed no copying in a total of 113 offspring of males where conditional *Cas9* expression was induced by either *Vasa-Cre* or *Stra8-Cre* ([Table 1](#T1){ref-type="table"} and [Extended Data Table 4](#T5){ref-type="table"}). It is possible, however, that the number of families and of offspring in each family, which was limited by unexplained low male fertility, was insufficient to detect low efficiency copying in each of four genetic strategies. If there is indeed a difference between males and females in the efficiency of *Tyr^CopyCat^* copying, we can conceive of two potential explanations. First, despite equivalent genotypes in the male and female *Vasa-Cre* lineages, Cre, Cas9, and/or gRNA may not be well expressed in the male germline. However, the high frequency of white *Tyr^ch/null^* offspring suggests that DSB formation is very efficient in males. Second, spermatogonia continually undergo mitosis and produce new primary spermatocytes throughout the life of a male in mammals^[@R22]^. In contrast, oogonia directly enlarge without further mitosis to form all of the primary oocytes in the embryo^[@R23]^. The difference in the observed efficiency of inter-homologue HDR between females and males at this locus may therefore reflect a requirement for the precise timing of CRISPR/Cas9 activity to coincide with meiosis ([Fig. 3](#F3){ref-type="fig"}). NHEJ indels in males may result from DSB repair that occurs prior to the alignment of homologous chromosomes in Meiosis I. Similarly, the higher observed efficiency of inter-homologue HDR in females of the *H11-LSL-Cas9* conditional strategy may relate to the lower or delayed *Cas9* expression from the *H11* locus, compared to *Rosa26*, that was evident in the constitutive crosses ([Fig. 1d, e](#F1){ref-type="fig"} and [Extended Data Table 1](#T2){ref-type="table"} and [3](#T4){ref-type="table"}). Thus, in the *Vasa-Cre*; *H11-LSL-Cas9* mice, DSB formation may have been fortuitously delayed to fall within a more optimal window during female meiosis.

In summary, we demonstrate that the fundamental mechanism of a CRISPR/Cas9-mediated gene drive is feasible in mice. However, our comparison of eight different genetic strategies indicates that precise timing of Cas9 expression may present a greater challenge in rodents than in insects in order to restrict DSB formation to a window when breaks can be efficiently repaired by the endogenous meiotic recombination machinery. These data are therefore critical to the ongoing discussion about whether CRISPR/Cas9-mediated gene drives could be used to reduce invasive rodent populations, since it appears that both the optimism and concern are likely premature. Further optimization to increase the frequency of gene conversion in both males and females and to reduce the prevalence of drive-resistant alleles (NHEJ indels that alter the gRNA target site) would be necessary to achieve rapid and sustained suppression of wild populations^[@R24]--[@R29]^.

Nevertheless, the copying efficiencies we observed here would be more than sufficient for a broad range of laboratory applications. For example, the average observed copying rate of 44% using the most efficient genetic strategy in females (*Vasa-Cre*; *H11-LSL-Cas9*) combined ultra-tightly linked *Tyrosinase* mutations such that 22.5% of all offspring inherited a chromosome with both alleles, an impossibility by Mendelian inheritance. This observed average copying rate would also be expected to increase the inheritance of a single desired allele from 50% to 72%, and the highest rate of gene conversion we observed (72.2%) would result in an 86% frequency of transmitting a desired allele. If multiple genes could be simultaneously converted to homozygosity, such high transmission frequencies that bypass the onerous constraint of genetic linkage stand to greatly accelerate the production of rodent models for a variety of complex genetic traits.
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![Knock-in strategy using the *Tyr^CopyCat^* targeting vector.\
The U6-Tyr4a-gRNA and CMV-mCherry were inserted into the cut site of the Tyr4a-gRNA by homology directed repair after CRISPR/Cas9 DSB formation targeted by the Tyr4a-gRNA. See [Supplemental Methods](#SD2){ref-type="supplementary-material"} and [Supplementary Fig. 1 and 2](#SD2){ref-type="supplementary-material"} for additional details.](nihms-1516304-f0001){#F4}

![*Rosa26-Cas9* and *H11-Cas9* constitutive lineages have different numbers of unique NHEJ indels.\
Sanger sequencing of the Tyr4a-gRNA target exon amplified from tail tip genomic DNA using TyrHALF2 and TyrHARR2 primers as specified in [Supplementary Table 3](#SD2){ref-type="supplementary-material"}. Above: A single representative Sanger sequence trace of the bulk PCR product amplified from a *Rosa26-Cas9*, *Tyr*^*CopyCat*+^ F2 animal (*Rosa26* Family 1 in [Extended Data Table 3](#T4){ref-type="table"}) with either major or minor peaks called revealing two distinct alleles. Five *Tyr*^*chinchilla*+^ F3 offspring of this F2 individual each match one of the two alleles \[marked 1 (insertion) and 2 (deletion)\]. Below: A single representative sequence trace of the bulk PCR product amplified from an *H11-Cas9*, *Tyr*^*CopyCat*+^ F2 animal (H11 Family 1 in [Extended Data Table 3](#T4){ref-type="table"}). Alternate alleles cannot be called because of the complexity of overlapping peaks. Five *Tyr*^*chinchilla*+^ F3 offspring each have one of four different alleles (marked 1, 2, 3, 4). Sequence trace data is representative of all 90 individuals total in five families of each constitutive strategy detailed in [Extended Data Table 3](#T4){ref-type="table"}.](nihms-1516304-f0002){#F5}

###### 

Coat color of F2 individuals that were constitutive *Cas9+* and *Tyr*^*CopyCat/chinchilla*^.

               Rosa26\>Cas9   H11\>Cas9
  ------------ -------------- -----------
  **White**    **17**         **3**
  **Mosaic**   **0**          **21**

###### 

Phenotypes and genotypes of all F3 progeny in [Fig. 1c](#F1){ref-type="fig"} that are the offspring of a subset of F2 individuals listed in [Extended Data Table 1](#T2){ref-type="table"}.

                                                                                                              Chinchilla + F3 offspring            
  ------------------------------------------------- -------------------- ------------------------------------ --------------------------- ---- --- ---
  Rosa26 Family 1                                   white                30                                   20                          20   0   0
  Rosa26 Family 2                                   white                11                                   15                          15   0   0
  Rosa26 Family 3[\*](#TFN1){ref-type="table-fn"}   white                28[\*](#TFN1){ref-type="table-fn"}   16                          16   0   0
  Rosa26 Family 4                                   white                22                                   22                          22   0   0
  Rosa26 Family 5                                   white                16                                   16                          16   0   0
                                                                                                                                                    
  H11 Family 1                                      prim. white mosak    14                                   15                          15   0   0
  H11 Family 2                                      print. grey mosak    23                                   28                          25   3   0
  H11 Family 3                                      prim. white mosaic   13                                   9                           9    0   0
  H11 Family 4                                      prim. white mosak    12                                   15                          15   0   0
  H11 Family 5                                      mosaic               23                                   24                          18   6   0

indicates a family with offspring that were *Tyr*^*chinchilla*^ negative and mCherry negative, suggesting a large deletion in the recipient chromosome may encompass the *Tyr*^*chinchilla*^ SNP

"prim." = "primarily" and refers to the coat color that covers the greatest total area when there was obviously not an equal proportion of white and grey

###### 

Allelic complexity of the constitutive Rosa26- and H11-Cas9 families.

  ----------------------------------------------------------------------------------------
                                                    Number of distinct NHEJ alleles in\
                                                    '*n*' *Tyr*^*chinchilla*^+ offspring
  ------------------------------------------------- --------------------------------------
  Rosa26 Family 1                                   2 (n=9)

  Rosa26 Family 2                                   3 (n=10)

  Rosa26 family 3[\*](#TFN3){ref-type="table-fn"}   2 (n=9)

  Rosa26 Family 4                                   2 (n=9)

  Rosa26 Family 5                                   3 (n=13)

                                                     

  H11 Family 1                                      4 (n=10)

  H11 Family 2                                      6 (n=9)

  H11 Family 3                                      4 (n=6)

  H11 Family 4                                      2 (n=8)

  H11 Family 5                                      7 (n=9)
  ----------------------------------------------------------------------------------------

indicates a family with offspring that were *Tyr*^*chinchilla*^ negative and mCherry negative, suggesting a large deletion in the recipient chromosome may encompass the *Tyr*^*chinchilla*^ SNP. This was counted as one of the two unique NHEJ indels.

###### 

Phenotypes and genotypes of all F4 progeny that are the offspring of a subset of F3 individuals listed in [Supplementary Table 4](#SD2){ref-type="supplementary-material"}.

  --
  --
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**Statistics and reproducibility:** The five families in each of the constitutive crosses ([Extended Data Table 2](#T3){ref-type="table"}) are considered five independent experiments with each F3 offspring representing an early embryonic DSB repair event in the F2 parent. Each F4 offspring in [Extended Data Table 4](#T5){ref-type="table"} represents a germline DSB repair event, an independent data point, and each family is considered an independent trial. No statistical method was used to predetermine sample size. Given breeding limitations, we assessed as many offspring as possible in each family and aimed to assess up to five families for each strategy. To detect gene conversion events, we used genetic linkage rather than a statistical test of inheritance greater than 50% expected by Mendelian segregation. Specifically, the receiver chromosome was marked with a SNP (*Tyr^ch^*) located \~ 9.1 kb from the target site for gene conversion. Since the average genetic distance for mouse chromosome 7 is 0.52 cM/Mb^[@R30]^, the probability of a naturally occurring recombination event that would unite these ultra-tightly linked loci onto the same chromosome is 4.7×10^−5^.

**Data availability:** All genotyping data for F3 offspring of constitutive crosses and F4 offspring of germline conditional crosses is available at [Zenodo.org](http://Zenodo.org) with the identifier 10.5281/zenodo.2003087. Annotated sequence data for the *Tyr^CopyCat^* transgene is available in Genbank with the accession number MK160997.

![Embryonic Cas9 activity does not copy the *Tyrosinase*^*CopyCat*^ allele from the donor to the receiver chromosome.\
(**a**) The genetically encoded *Tyr^CopyCat^* element, when combined with a transgenic source of Cas9, is expected to induce a DSB in the *Tyr*^*chinchilla*^-marked receiver chromosome, which could be repaired by inter-homologue HDR. (**b**) Breeding strategy to unite *Tyr^CopyCat^* with a constitutive *Cas9* transgene followed by test cross to *Tyr^null^*. (**c**) Sum of F3 test cross offspring from five independent families for each *Rosa26-Cas9* and *H11-Cas9* genotype. (**d**) A representative of six *Rosa26-Cas9* F2 litters. Black mice did not inherit *Tyr^CopyCat^*. Grey mice inherited *Tyr^CopyCat^* but not *Cas9*. White mice inherited both transgenes. (**e**) A representative of five F2 litters in which all offspring inherited *H11-Cas9*. The mosaic mice also inherited *Tyr^CopyCat^*.](nihms-1516304-f0003){#F1}

![Breeding strategy to produce *Tyr*^*CopyCat/chinchilla*^ mice with a conditional *Cas9* transgene and a germline restricted *Cre* transgene.\
F3 offspring were test crossed to *Tyr^null^* animals to assess F4 phenotypes and genotypes. Quantification of observed outcomes in F4 test cross offspring are presented in [Table 1](#T1){ref-type="table"}.](nihms-1516304-f0004){#F2}

![Gene conversion by an active genetic element was observed in the female germline and not in the male germline or in the early embryo.\
Schematic representation of early embryonic and male and female germline development overlaid with the presence or absence of observed HDR. \[PGCs: primordial germ cells, n: number of homologous chromosomes, c: chromosome copy number. Asterisk indicates the difference between male sperm (n, 1c) and female ovum, which remains (n, 2c) until second polar body extrusion after fertilization.\]](nihms-1516304-f0005){#F3}

###### 

Observed F4 outcomes of germline Cas9 strategies.

  ------------------------------------------------------------------------------------------------
  Cre         Cas9         F3 parent\   No cut or\    NHEJ\        HDR\         %HDR\         
                           (F)emale\    functional\   disruption   conversion   conversion\   
                           or (M)ale    repair                                  observed      
  ----------- ------------ ------------ ------------- ------------ ------------ ------------- ----
  **Vasa**    **Rosa26**   **F**        **1**         \-           15           \-            \-

  **2**       1            2            \-            \-                                      

  **3**       \-           3            1             25%                                     

  **4**       4            5            3             25%                                     

  **5**       6            6            1             8%                                      

                                                                                              

  **M**       **1**        \-           25            \-           \-                         

  **2**       \-           17           \-            \-                                      

                                                                                              

  **H11**     **F**        **1**        4             1            13           72%           

  **2**       10           7            4             19%                                     

  **3**       4            \-           5             56%                                     

  **4**       8            4            4             25%                                     

  **5**       8            3            10            48%                                     

                                                                                              

  **M**       **1**        \-           15            \-           \-                         

  **2**       \-           5            \-            \-                                      

  **3**       \-           2            \-            \-                                      

  **4**       \-           3            \-            \-                                      

                                                                                              

  **Stra8**   **Rosa26**   **F**        **1**         \-           19           \-            \-

  **2**       \-           3            \-            \-                                      

                                                                                              

  **H11**     **M**        **1**        3             21           \-           \-            
  ------------------------------------------------------------------------------------------------

[^1]: Current address: Department of Medicine, National University of Singapore, Singapore 119228, Republic of Singapore.

[^2]: **Author information:** Reprints and permissions information is available at [www.nature.com/reprints](http://www.nature.com/reprints). The authors declare competing financial interests: V.M.G., E.B., and K.L.C. hold advisory board positions with Synbal, Inc. All other authors declare that they have no competing interests. Correspondence and requests for materials should be addressed to K.L.C (<kcooper@ucsd.edu>).

[^3]: **Author contributions:** H.A.G., V.M.G., G.P., E.B., and K.L.C. conceived and designed the research; V.M.G. and G.P. designed and cloned the *Tyr^CopyCat^* transgene and validated mCherry expression *in vitro*; X.S.X. validated Tyr4a-gRNA cleavage activity *in vitro*; H.A.G. and K.L.C. designed the breeding strategies; H.A.G. acquired and established mouse lines, developed genotyping protocols, and conducted mouse breeding, phenotyping, and genotyping; H.A.G. curated the data and analyses; K.L.C. and E.B. supervised the research; K.L.C. wrote the original draft; H.A.G., V.M.G., E.B., and K.L.C. revised subsequent drafts.
